EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis

Andraž Nendl iD, Sajan C Raju, Peder R Braadland iD, Anna Nordborg, Vibeke Bratseth, Kaspar Broch, Silje F Jørgensen, Pål Aukrust, Karsten Kristiansen, Johannes R Hov, Marius Trøseid, Ayodeji Awoyemi

PLOS One · 2025

DOI: 10.1371/journal.pone.0331692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Andraž Nendl und 11 weiteren Autor:innen. Beteiligte Einrichtung: Oslo Center for Clinical Heart Research, Department of Cardiology Ullevaal, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Dysbiosis, Heart Failure, Gastrointestinal Microbiome. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges ForskningsrÃ¥d, Marie Stenberg’s trust for research of cardiovascular diseases, Blix foundation for the promotion of medical research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The gut microbiota produces numerous metabolites that can enter the circulation and exert effects outside the gut. Several studies have reported altered gut microbiota composition and circulating metabolites in patients with chronic heart failure (HF) compared to healthy controls. Limited data is available on the interplay between dysbiotic features of the gut microbiota and altered circulating metabolites in HF patients. We aimed to examine differences in circulating metabolites between people with and without chronic HF, and their association with gut microbiota dysbiosis and cardiac function.

Methods

We collected plasma, serum, and stool samples from 123 adult patients with stable chronic HF and left ventricular ejection fraction (LVEF) ≤40%, and healthy controls (plasma: n = 51, stool samples: n = 69). Metabolomic and lipidomic profiling of plasma was performed using liquid chromatography with tandem mass spectrometry. Principal component analysis was used to explore differences in circulating profiles. Over-representation analysis was performed to identify pathways in which relevant metabolites were involved. Stool samples were sequenced using shotgun metagenomics. We calculated a dysbiosis index based on differential abundances of microbial taxa in patients vs. controls.

Results

After adjusting for age, sex, and sampling location, we identified 67 enriched metabolites and 24 enriched lipids, and 115 depleted metabolites and 6 depleted lipids in HF patients compared to healthy controls. LVEF, N-terminal pro B-type natriuretic peptide, gut leakage markers, dysbiosis index, and fiber intake were not significantly related to any of the differentially abundant metabolites or lipids. Pathways related to energy metabolism differed most between HF patients and controls, however medication adjustment abolished all differences in circulating profiles.

Conclusions

Patients with chronic HF had distinct metabolomic and lipidomic profiles and energy metabolism differed significantly compared to healthy controls before adjusting for medication use. However, the alterations were not related to gut dysbiosis, gut leakage markers, cardiac function, or fiber intake.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisHeart FailureGastrointestinal MicrobiomeHumansMaleFemaleMiddle AgedAgedFecesChronic DiseaseCase-Control StudiesMetabolomicsMetabolome

Autor:innen und Institutionen

  • Oslo Center for Clinical Heart Research, Department of Cardiology Ullevaal, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
  • Department of Cardiology Rikshospitalet, Oslo University Hospital, Oslo, Norway.

ORCID-Profile: Andraž Nendl, Peder R Braadland

Förderung

  • Norges ForskningsrÃ¥d
  • Marie Stenberg’s trust for research of cardiovascular diseases
  • Blix foundation for the promotion of medical research
  • Nasjonalforeningen for Folkehelsen
  • Stein Erik Hagen's Foundation for Clinical Heart Research
  • Ada og Hagbart Waages humanitære og veldedige stiftelse

Zitieren

APA

Nendl, A., Raju, S. C., Braadland, P. R., Nordborg, A., Bratseth, V., Broch, K., Jørgensen, S. F., Aukrust, P., Kristiansen, K., Hov, J. R., Trøseid, M., & Awoyemi, A. (2025). Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis. PLOS One. https://doi.org/10.1371/journal.pone.0331692

Vancouver

Nendl A, Raju SC, Braadland PR, Nordborg A, Bratseth V, Broch K, et al. Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis. PLOS One. 2025. doi:10.1371/journal.pone.0331692

BibTeX
@article{Nendl2025,
  author = {Nendl, Andraž and Raju, Sajan C and Braadland, Peder R and Nordborg, Anna and Bratseth, Vibeke and Broch, Kaspar and Jørgensen, Silje F and Aukrust, Pål and Kristiansen, Karsten and Hov, Johannes R and Trøseid, Marius and Awoyemi, Ayodeji},
  title = {Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0331692}
}
Kostenlos starten →